C-reactive protein and D-dimer with clinical probability score in the exclusion of pulmonary embolism Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008
D-dimer to C-reactive protein (CRP) ratio in patients with suspected pulmonary embolism Source: Annual Congress 2010 - Pulmonary embolism Year: 2010
Prediction of the severity of pulmonary embolism according to clinical pre-test and D-dimer concentration Source: Eur Respir J 2006; 28: Suppl. 50, 402s Year: 2006
Relationship between severity of disease and D-dimer levels which were measured with two different methods in pulmonary embolism patients Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases Year: 2009
D-dimer is of limited value in the diagnosis of pulmonary embolism Source: Eur Respir J 2003; 22: Suppl. 45, 218s Year: 2003
Clinical usefulness of D-dimer according to clinical probability in patients with suspected pulmonary embolism Source: Eur Respir J 2003; 22: Suppl. 45, 220s Year: 2003
Value of serum procalcitonin levels in the differential diagnosis of pneumonia and pulmonary embolism Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011
The diagnostic value of serum procalcitonin in differential diagnosis of pulmonary embolism and pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 462s Year: 2007
Prognostic value of D-dimer, BNP and CRP in acute pulmonary thromboembolism and relationship with echocardiography Source: Annual Congress 2010 - Pulmonary embolism Year: 2010
The comparison of diagnostic relevance of protein C, C-reactive protein and endothelin-1 for prediction of lung vessel thrombosis in patients with community-acquired pneumonia Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019
Diagnostic value of d-dimer in the diagnosis of pulmonary embolism in pregnancy Source: Virtual Congress 2020 – Pulmonary embolism and beyond Year: 2020
Clinical probability and d-dimer utility in the context of suspected pulmonary embolism: The safe approach Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease Year: 2010
Comparison between semiquantitative and quantitative measurements of D-dimers for the diagnosis of pulmonary embolism Source: Eur Respir J 2003; 22: Suppl. 45, 462s Year: 2003
The relationship between level of C-reactive protein in blood serum and clinical manifestations of the disease in patients with pulmonary tuberculosis Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010
Clinical usefulness of D-dimer in cancer patients with suspected pulmonary embolism Source: Eur Respir J 2003; 22: Suppl. 45, 220s Year: 2003
Prognostic value of two clinical scores in patients with acute symptomatic pulmonary embolism Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011
Pulmonary Embolism: Incidence, spectrum of CTPA findings, and correlation of D-dimers with embolus location. Is age-adjusted D-dimers cutoff a better screening method? Source: Virtual Congress 2021 – Insights into pulmonary embolism Year: 2021
Prognostic value of D-dimer and troponin I in submassive pulmonary embolism Source: Annual Congress 2009 - Pulmonary embolism Year: 2009
Pulmonary embolism severity index and D-dimer for risk-stratification of patients with acute pulmonary embolism Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders Year: 2010
Comparison of the clinical probability scores and diagnostic tests of deep venous thrombosis and pulmonary embolism Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008